August 19, 2025

agilon health, inc. (AGL) Stock Analysis: Evaluating the 41% Potential Upside Amid Market Challenges

As an intriguing player in the healthcare sector, agilon health, inc. (NYSE: AGL) has caught the attention of investors with its innovative approach to senior healthcare services. Despite facing some..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Navigating Growth with a 4.84% Upside Potential

GoodRx Holdings, Inc. (NASDAQ: GDRX), a prominent player in the health information services industry, offers a unique platform enabling consumers to compare and save on prescription drug purchases across the..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a Potential 108% Upside

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is currently a focal point within the healthcare sector, specifically in the medical devices industry. With a market capitalization of $732.45 million, this U.S.-based..

Certara, Inc. (CERT) Stock Analysis: Unveiling a 26% Potential Upside in Healthcare Technology

Certara, Inc. (NASDAQ: CERT) stands at the intersection of healthcare and technology, offering a compelling investment opportunity with a potential upside of over 26%, as suggested by current analyst ratings...

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: High Revenue Growth and Analyst Confidence Signal Potential Upside

Investors looking at ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) may find themselves intrigued by the impressive revenue growth and the bullish sentiment from analysts that hint at a potential upside in..

Addus HomeCare Corporation (ADUS) Stock Analysis: A 21% Upside Potential in the Booming Healthcare Sector

Addus HomeCare Corporation (NASDAQ: ADUS), a prominent player in the healthcare sector, has captured investor attention with its robust outlook and significant growth potential. Specializing in personal care services for..

Evotec SE (EVO) Stock Analysis: A 56% Upside Potential Amidst Strategic Collaborations

Evotec SE (EVO), a prominent player in the healthcare sector, operates as a drug discovery and development company with a significant presence in the United States, Germany, France, the United..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Eyeing a 37% Upside in the Biotech Arena

PTC Therapeutics, Inc. (NASDAQ: PTCT) stands at the forefront of the biotechnology industry with its innovative focus on rare disorders. The company’s current market capitalization is $3.96 billion, reflecting its..

Belite Bio, Inc (BLTE) Stock Analysis: Biotechnology Innovator with 44.34% Upside Potential

Belite Bio, Inc (BLTE) is a promising player in the healthcare sector, specifically within the biotechnology industry. Based in San Diego, California, this clinical-stage biopharmaceutical company focuses on developing novel..

Harrow, Inc. (HROW) Stock Analysis: 56.84% Upside Potential in the Thriving Eyecare Pharmaceutical Market

For investors with an eye on the healthcare sector, Harrow, Inc. (NASDAQ: HROW) presents an intriguing opportunity. As a key player in the eyecare pharmaceutical industry, Harrow has carved out..

Innoviva, Inc. (INVA) Stock Analysis: Unraveling a 97% Potential Upside in Healthcare Innovation

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, is capturing investors’ attention with its robust portfolio of pharmaceutical products and a significant potential upside of 97.31%. Headquartered..

Integra LifeSciences Holdings C (IART) Stock Analysis: Navigating a 12.99% Potential Upside Amidst Market Challenges

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a key player in the healthcare sector, specifically within the medical devices industry, finds itself at a pivotal juncture. With a market capitalization of..

Amedisys Inc (AMED) Stock Analysis: Navigating Growth in the Healthcare Sector

Amedisys Inc (NASDAQ: AMED), a prominent player in the healthcare sector, continues to capture investor attention with its robust service offerings and strategic positioning in the U.S. medical care facilities..

Aurinia Pharmaceuticals Inc (AUPH): Analyst Consensus and Growth Potential in Autoimmune Therapies

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has carved out a niche within the biotechnology sector by focusing on therapies for autoimmune diseases, an area characterized by high unmet medical needs. With..

HUTCHMED (China) Limited (HCM)

⚠️ No article content returned.

..

Surgery Partners, Inc. (SGRY): Investor Outlook on a Healthcare Innovator with 37.84% Upside Potential

Surgery Partners, Inc. (NASDAQ: SGRY) stands out as a dynamic entity within the healthcare sector, offering investors a unique proposition in the medical care facilities industry. Headquartered in Brentwood, Tennessee,..

Brookdale Senior Living Inc. (BKD) Investor Outlook: Navigating Challenges with a 13% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD) stands as a significant player within the healthcare sector, specifically in the medical care facilities industry. Headquartered in Brentwood, Tennessee, Brookdale operates a vast..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 16.5% Upside Potential in Non-Opioid Pain Management

Pacira BioSciences, Inc. (NASDAQ: PCRX) stands at the forefront of the healthcare sector, specializing in innovative non-opioid pain management solutions. With a market cap of $1.12 billion, this Tampa, Florida-based..

Adaptive Biotechnologies (ADPT) Stock Analysis: A Promising 12.81% Upside in the Evolving Biotech Sector

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) stands out in the biotechnology sector with its innovative approach to immune medicine through its proprietary immunosequencing platform. Headquartered in Seattle, Washington, this commercial-stage company..

Organon & Co. (OGN) Stock Analysis: Exploring a 41.88% Potential Upside Amid Diverse Healthcare Offerings

Organon & Co. (NYSE: OGN) is carving its niche in the healthcare sector, particularly within the drug manufacturing industry. Headquartered in Jersey City, New Jersey, this company is a global..

Search

Funds

August 19, 2025

Search

Funds

August 19, 2025

FTSE 100

Funds